- Heaton, Nicholas S;
- Moshkina, Natasha;
- Fenouil, Romain;
- Gardner, Thomas J;
- Aguirre, Sebastian;
- Shah, Priya S;
- Zhao, Nan;
- Manganaro, Lara;
- Hultquist, Judd F;
- Noel, Justine;
- Sachs, David;
- Hamilton, Jennifer;
- Leon, Paul E;
- Chawdury, Amit;
- Tripathi, Shashank;
- Melegari, Camilla;
- Campisi, Laura;
- Hai, Rong;
- Metreveli, Giorgi;
- Gamarnik, Andrea V;
- García-Sastre, Adolfo;
- Greenbaum, Benjamin;
- Simon, Viviana;
- Fernandez-Sesma, Ana;
- Krogan, Nevan J;
- Mulder, Lubbertus CF;
- van Bakel, Harm;
- Tortorella, Domenico;
- Taunton, Jack;
- Palese, Peter;
- Marazzi, Ivan
Viruses are obligate parasites and thus require the machinery of the host cell to replicate. Inhibition of host factors co-opted during active infection is a strategy hosts use to suppress viral replication and a potential pan-antiviral therapy. To define the cellular proteins and processes required for a virus during infection is thus crucial to understanding the mechanisms of virally induced disease. In this report, we generated fully infectious tagged influenza viruses and used infection-based proteomics to identify pivotal arms of cellular signaling required for influenza virus growth and infectivity. Using mathematical modeling and genetic and pharmacologic approaches, we revealed that modulation of Sec61-mediated cotranslational translocation selectively impaired glycoprotein proteostasis of influenza as well as HIV and dengue viruses and led to inhibition of viral growth and infectivity. Thus, by studying virus-human protein-protein interactions in the context of active replication, we have identified targetable host factors for broad-spectrum antiviral therapies.